Brief: Outlook Therapeutics Q1 EPS USD -0.38
17/02/2026 13:05
Feb 17 (Reuters) - Outlook Therapeutics Q1 adjusted EPS USD -0.22. Q1 net income USD -23.1 million
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce